[go: up one dir, main page]

UY28372A1 - Agentes terapéuticos - Google Patents

Agentes terapéuticos

Info

Publication number
UY28372A1
UY28372A1 UY28372A UY28372A UY28372A1 UY 28372 A1 UY28372 A1 UY 28372A1 UY 28372 A UY28372 A UY 28372A UY 28372 A UY28372 A UY 28372A UY 28372 A1 UY28372 A1 UY 28372A1
Authority
UY
Uruguay
Prior art keywords
salt
ethyl
therapeutic agents
szal
dyslipidemias
Prior art date
Application number
UY28372A
Other languages
English (en)
Inventor
Matti Ahlqvist
Mikael Ulf Johan Dahlstrom
Bengt Ohlsson
Richard Anthony Storey
Nigel Philip Taylor
Rebecca Jane Woods
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY28372A1 publication Critical patent/UY28372A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una sal de terc-butilamina, una sal de piperazina, una szal de colina, una sal de tris (hidroximetil)metilamina, una sal de lisina o una sal de adamantilamina del ácido (-)-2-((2-(4-hidroxifenil)etil)-tio)-3-(4-(2-(4-((metilsulfonil)oxi)fenoxi)etil)fenil)propanoico, procesos para su preparación, su uso en el tratamiento de trastornos clínicos incluidos trastornos lipídicos (dislipidemias) asociadas o no con resistencia a la insulina y otras manifestaciones del síndrome metabólico y composiciones farmacéuticas que las contengan.
UY28372A 2003-06-18 2004-06-17 Agentes terapéuticos UY28372A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0314130.6A GB0314130D0 (en) 2003-06-18 2003-06-18 Therapeutic agents

Publications (1)

Publication Number Publication Date
UY28372A1 true UY28372A1 (es) 2005-01-31

Family

ID=27636789

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28372A UY28372A1 (es) 2003-06-18 2004-06-17 Agentes terapéuticos

Country Status (20)

Country Link
US (1) US20070099928A1 (es)
EP (1) EP1638930A1 (es)
JP (1) JP3927594B2 (es)
KR (1) KR20060023165A (es)
CN (1) CN1835919A (es)
AR (1) AR044826A1 (es)
AU (1) AU2004249483A1 (es)
BR (1) BRPI0411580A (es)
CA (1) CA2529544A1 (es)
CO (1) CO5630026A2 (es)
GB (1) GB0314130D0 (es)
IL (1) IL172633A0 (es)
IS (1) IS8224A (es)
MX (1) MXPA05013718A (es)
NO (1) NO20056006L (es)
RU (1) RU2005141061A (es)
TW (1) TW200503671A (es)
UY (1) UY28372A1 (es)
WO (1) WO2004113283A1 (es)
ZA (1) ZA200510263B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0104333D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
CN1319938C (zh) 2002-06-20 2007-06-06 阿斯特拉曾尼卡有限公司 治疗胰岛素抵抗的邻位取代的苯甲酸衍生物
GB0314131D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0314075D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0427524D0 (en) 2004-12-16 2005-01-19 Astrazeneca Ab Chemical process
GB0427701D0 (en) * 2004-12-17 2005-01-19 Astrazeneca Ab Therapeutic agents
WO2008089464A1 (en) * 2007-01-18 2008-07-24 Evolva Sa Prodrugs of substituted 1,3-dioxanes and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
MA26634A1 (fr) * 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues
SE0104333D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents

Also Published As

Publication number Publication date
IL172633A0 (en) 2006-04-10
NO20056006L (no) 2006-02-24
GB0314130D0 (en) 2003-07-23
EP1638930A1 (en) 2006-03-29
CA2529544A1 (en) 2004-12-29
AR044826A1 (es) 2005-10-05
ZA200510263B (en) 2007-02-28
MXPA05013718A (es) 2006-06-27
US20070099928A1 (en) 2007-05-03
BRPI0411580A (pt) 2006-08-08
IS8224A (is) 2006-01-10
RU2005141061A (ru) 2006-08-27
TW200503671A (en) 2005-02-01
CO5630026A2 (es) 2006-04-28
AU2004249483A1 (en) 2004-12-29
JP3927594B2 (ja) 2007-06-13
KR20060023165A (ko) 2006-03-13
CN1835919A (zh) 2006-09-20
WO2004113283A1 (en) 2004-12-29
JP2006527749A (ja) 2006-12-07

Similar Documents

Publication Publication Date Title
DOP2020000250A (es) Compuestos antagonistas de la pcsk9
PA8537201A1 (es) Agonistas de ppar
AR042632A1 (es) Compuestos derivados del acido (2s)-3-(4-{2-[amino]-2-oxoetoxi} fenil)-2-etoxipropanoico como agentes terapeuticos para trastornos en el metabolismo de los lipidos y composiciones farmaceuticas
ECSP066302A (es) Omega-carboxiaril-difenil-urea sustituida con flúor para el tratamiento y la prevención de enfermedades y afecciones
UA100966C2 (ru) Фармацевтическая композиция на основе 2-[4-(4-хлорбензоил)фенокси]-2-метилпропионовой кислоты и ее солей
PA8539101A1 (es) Compuestos de ppar
CO5650227A2 (es) Derivados del acido propionico utiles en desordenes lipidicos
BRPI0416639A (pt) tiromiméticos contendo fósforo
AR054261A1 (es) Sales fisiologicamente compatibles de ester etilico del acido 3-(2-{(4-(hexiloxicarbonilamino-imino-metil )-fenilamino]-metil}-1-metil-1h-bencimidazol-5-carbonil)-piridin-2-il-amino)-propionico, composiciones farmaceuticas que las contienen y su uso en la preparacion de un medicamento para la profil
AR060991A1 (es) Acidos carboxilicos sustituidos con 4,5-difenilpirimidinilo y composiciones farmaceuticas que los contienen utilizadas para el tratamiento de la diabetes
ES2152222T3 (es) Sulfonamidas, su preparacion y su uso como medicamento e intermedio.
MX338338B (es) Composiciones y metodos utiles para el tratamiento de enfermedades respiratorias.
BR0015048A (pt) Sal farmacêutico, medicamento, uso de pelo menos um sal de tramadol e formas de apresentação
AR029412A1 (es) Forma cristalina
BR112014011981A2 (pt) formulações farmacêuticas
UY28372A1 (es) Agentes terapéuticos
ECSP055985A (es) Derivados de ácido 3-metil-2-(3-(2-fenil-oxazol-4-ilmetoxi)-ciclohexanocarbonil-aminobutírico y compuestos relacionados como moduladores de ppar para el tratamiento de diabetes de tipo 2 y aterosclerosis
BRPI0616659A8 (pt) droga terapêutica antituberculose, medicamento, e, kit para o tratamento de tuberculose
BRPI0412835A (pt) processo para preparação de uma solução de alfa-1-antitripsina
PE20100467A1 (es) Compuesto mono-l-malato (r)-3-((e)-2-(pirrolidin-3-il)vinil)-5-(tetrahidropiran-4-iloxi)piridina y composiciones que lo contienen
UY28367A1 (es) Agentes terapéuticos
BR0307009A (pt) Sais estáveis de ácido o-acetilsalicìlico com aminoácidos básicos ii
CO5680411A2 (es) Compuestos del 1-fenil-2-dimetilamino-metil-ciclohexano, para la terapia de sintomatologia depresiva, dolor e incontinencia
AR044802A1 (es) Sales farmaceuticamente aceptables, de derivados de acidos carboxilicos
AR051998A1 (es) Agentes terapeuticos

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150604